Dermatology NewsA White male presented with a 1-month history of recurrent, widespread, painful soresSeptember 19, 2022Infectious DiseasesMedical Dermatology
Dermatology NewsHouse passes prior authorization bill, Senate path unclearSeptember 19, 2022Business of MedicinePractice Management
Meta-analysis demonstrates potential of probiotics in reducing atopic dermatitis disease severitySeptember 19, 2022Atopic Dermatitis
Real-world characteristics of patients with moderate-to-severe atopic dermatitis receiving dupilumabSeptember 19, 2022Atopic Dermatitis
Pediatric atopic dermatitis and neuropsychiatric disorders: What is the link?September 19, 2022Atopic Dermatitis
Early initiation of emollient reduces risk for atopic dermatitis in high risk infantsSeptember 19, 2022Atopic Dermatitis
Moderate-to-severe atopic dermatitis: Astegolimab fails to reduce disease severity in phase 2 trialSeptember 19, 2022Atopic Dermatitis
EHA cream shows promise in children with mild-to-moderate atopic dermatitisSeptember 19, 2022Atopic Dermatitis
Rapid itch reduction with ruxolitinib in mild-to-moderate atopic dermatitisSeptember 19, 2022Atopic Dermatitis
Brepocitinib shows potential against mild-to-moderate atopic dermatitis in phase 2 trialSeptember 19, 2022Atopic Dermatitis
Meta-analysis finds no increased VTE risk in AD patients receiving JAK inhibitorsSeptember 19, 2022Atopic Dermatitis
Dupilumab shows good drug survival in moderate-to-severe atopic dermatitisSeptember 19, 2022Atopic Dermatitis
Dermatology NewsBrodalumab suicide risk similar to other biologics, postmarket study findsSeptember 19, 2022PsoriasisPsoriatic ArthritisMixed Topics